Attovia Therapeutics, Inc. Ttl Fee Amt
Attovia Therapeutics, Inc. (ATTO) had Ttl Fee Amt of $14.64 thousand as of 2026-08-05, per its S-8 filed 2026-08-06.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-08-06
- 2026-08-05: Ttl Fee Amt $14.64K.
- 2026-08-04: Ttl Fee Amt $45.90K.
- 2026-07-28: Ttl Fee Amt $33.75K.
- 2026-07-07: Ttl Fee Amt $13.81K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-08-05 | $14.64K S-8 · filed 2026-08-06 |
| 2026-08-04 | $45.90K S-1/A · filed 2026-08-04 |
| 2026-07-28 | $33.75K S-1/A · filed 2026-07-29 |
| 2026-07-07 | $13.81K S-1 · filed 2026-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |